Table 1.

Distribution of CALR exon 9 mutations detected in the cohorts of Greek ET and MF patients.

Essential thrombocythaemia
	Type-1	Type-1 like	Type-2	Type-2 like	Complex type	Mutations detected	Samples
n	46	6	34	1	3	90	130
%	51.11 *	6.67 *	37.78 *	1.11 *	3.33 *	69.23 **
Primary myelofibrosis
	Type-1	Type-1 like	Type-2	Type-2 like	Complex type	Mutations detected	Samples
n	13	2	3	0	0	18	33
%	72.22 *	11.11 *	16.67 *	0.00 *	0.00 *	54.55 **
Myelofibrosis secondary to ET
	Type-1	Type-1 like	Type-2	Type-2 like	Complex type	Mutations detected	Samples
n	3	1	4	0	1	9	10
%						90.00 **

^*Percentage of mutation subtypes versus overall mutations detected.

^**Percentage of mutations detected versus samples under investigation.